Biblio Discovery — Demo Discovery Service

16 results for "Rob W.J. Collin"

Showing 1–16 · 0.22 seconds · RSS

  1. Journal Article Full text

    Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations

    Frans P.M. Cremers; Winston Lee; Rob W.J. Collin et al.

    Progress in Retinal and Eye Research · 2020 · English · OpenAlex Scopus

    The ABCA4 protein (then called a "rim protein") was first identified in 1978 in the rims and incisures of rod photoreceptors. The corresponding gene, ABCA4, was cloned in 1997, and variants were identified as the cause of autosomal recessive Stargardt disease (STGD1). Over the next two decades…

  2. Journal Article

    Generation of three isogenic control lines from patient-derived iPSCs carrying bi-allelic ABCA4 variants underlying Stargardt disease

    Dyah W. Karjosukarso; Femke Bukkems; Lonneke Duijkers et al.

    Stem Cell Research, Vol. 71 · 2023 · English · DOAJ Scopus

    Stargardt disease, a progressive retinal disorder, is associated with bi-allelic variants in ABCA4. Employing the CRISPR/Cas9 approach, we generated isogenic control lines (RMCGENi005-A-1, RMCGENi018-A-1, RMCGENi017-A-1) for each of three induced pluripotent stem cell lines (RMCGENi005-A…

  3. Journal Article

    Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics

    Annemieke Aartsma-Rus; Rob W.J. Collin; Ype Elgersma et al.

    Therapeutic Advances in Rare Disease, Vol. 5 · 2024 · English · DOAJ Scopus

    Antisense oligonucleotides (ASOs) offer versatile tools to modify the processing and expression levels of gene transcripts. As such, they have a high therapeutic potential for rare genetic diseases, where applicability of each ASO ranges from thousands of patients worldwide to single individuals…

  4. Journal Article

    Generation of iPSC lines from three Stargardt patients carrying bi-allelic ABCA4 variants

    Dyah W. Karjosukarso; Femke Bukkems; Lonneke Duijkers et al.

    Stem Cell Research, Vol. 71 · 2023 · English · DOAJ Scopus

    Stargardt disease, a progressive retinal disorder, is associated with bi-allelic variants in ABCA4, a protein that is expressed in the retina. Induced pluripotent stem cell lines (RMCGENi005-A, SCTCi018-A, SCTCi017-A) were generated by lentivirus reprogramming of fibroblasts derived from Stargardt…

  5. Journal Article

    Generation of an iPSC line (RMCGENi020-A) from a patient with Stargardt disease harboring the recurrent intronic ABCA4 variant c.4253+43G>A

    Nuria Suárez-Herrera; Nico Leijsten; Silvia Albert et al.

    Stem Cell Research, Vol. 73 · 2023 · English · DOAJ Scopus

    Pathogenic variants in ABCA4 are associated with Stargardt disease (STGD1), an autosomal recessive macular dystrophy characterized by bilateral central vision loss due to a progressive degeneration of retinal cells. An induced pluripotent stem cell (iPSC) line was generated from late-onset STGD1…

  6. Journal Article

    Generation of a patient-derived induced pluripotent cell line (SCTCi016-A) carrying a homozygous variant in RPE65

    Irene Vázquez-Domínguez; Michael Kwint; Hester Y Kroes et al.

    Stem Cell Research, Vol. 60 · 2022 · English · DOAJ Scopus

    Leber congenital amaurosis (LCA) can be caused by mutations in more than 20 different genes. One of these, RPE65, encodes a protein essential for the visual cycle that is expressed in retinal pigment epithelium cells. In this work, we describe the generation and characterization of the human iPSC…

  7. Journal Article

    Gene augmentation of LCA5-associated Leber congenital amaurosis ameliorates bulge region defects of the photoreceptor ciliary axoneme

    Siebren Faber; Olivier Mercey; Katrin Junger et al.

    JCI Insight, Vol. 8 No. 10 · 2023 · English · DOAJ Scopus

    Leber congenital amaurosis (LCA) is a group of inherited retinal diseases characterized by early-onset, rapid loss of photoreceptor cells. Despite the discovery of a growing number of genes associated with this disease, the molecular mechanisms of photoreceptor cell degeneration of most LCA…

  8. Journal Article

    A Comparison of Randomizing Either One Eye or Both Eyes in Clinical Trials for Stargardt Disease Type 1

    Jeroen A.A.H. Pas, MD; Patty P.A. Dhooge, MD, PhD; Catherina H.Z. Li, MD et al.

    Ophthalmology Science, Vol. 6 No. 2 · 2026 · English · DOAJ Scopus

    Objective: Designing a clinical trial for rare diseases such as Stargardt disease type 1 is challenging due to the limited patient population. In traditional clinical trial designs for inherited retinal diseases, often only 1 eye of each patient is used as the treated eye or the sham, disregarding…

  9. Journal Article

    Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C

    Melita Kaltak; Petra de Bruijn; Davide Piccolo et al.

    Molecular Therapy: Nucleic Acids, Vol. 31 · 2023 · English · DOAJ Scopus

    Stargardt disease type 1 (STGD1) is the most common hereditary form of maculopathy and remains untreatable. STGD1 is caused by biallelic variants in the ABCA4 gene, which encodes the ATP-binding cassette (type 4) protein (ABCA4) that clears toxic byproducts of the visual cycle. The c.5461-10T>C…

  10. Journal Article

    Exploring extracellular vesicle MicroRNAs in Usher syndrome type 1B: Tear-Derived EVs as potential indicators of retinal health

    Sander Bervoets; Lonneke Duijkers; Hedwig M. Velde et al.

    Cellular and Molecular Life Sciences, Vol. 83 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Usher syndrome type 1B (USH1B) is a rare inherited disorder characterized by congenital deafness and progressive retinitis pigmentosa, caused by biallelic pathogenic variants in the MYO7A gene. We explored extracellular vesicles (EVs) from two sources: human tears and iPSC-derived RPE…

  11. Journal Article

    CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids

    Tess A.V. Afanasyeva; Dimitra Athanasiou; Pedro R.L. Perdigao et al.

    Molecular Therapy: Methods & Clinical Development, Vol. 29 · 2023 · English · DOAJ

    Mutations in the lebercilin-encoding gene LCA5 cause one of the most severe forms of Leber congenital amaurosis, an early-onset retinal disease that results in severe visual impairment. Here, we report on the generation of a patient-specific cellular model to study LCA5-associated retinal disease…

  12. Journal Article Full text

    Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

    Suzan M. Hammond; Annemieke M Aartsma-Rus; Sandra Alves et al.

    EMBO Molecular Medicine · 2021 · English · OpenAlex Scopus

    Nucleic acid-based therapeutics that regulate gene expression have been developed towards clinical use at a steady pace for several decades, but in recent years the field has been accelerating. To date, there are 11 marketed products based on antisense oligonucleotides, aptamers and small…

  13. Journal Article

    Lipopeptide-mediated Cas9 RNP delivery: A promising broad therapeutic strategy for safely removing deep-intronic variants in ABCA4

    Irene Vázquez-Domínguez; Mert Öktem; Florian A. Winkelaar et al.

    Molecular Therapy: Nucleic Acids, Vol. 35 No. 4 · 2024 · English · DOAJ Scopus

    Deep-intronic (DI) variants represent approximately 10%–12% of disease-causing genetic defects in ABCA4-associated Stargardt disease (STGD1). Although many of these DI variants are amenable to antisense oligonucleotide-based splicing-modulation therapy, no treatment is currently available. These…

  14. Journal Article

    Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models

    Kalyan Dulla; Monica Aguila; Amelia Lane et al.

    Molecular Therapy: Nucleic Acids, Vol. 12 · 2018 · English · DOAJ Scopus

    Leber congenital amaurosis type 10 (LCA10) is a severe inherited retinal dystrophy associated with mutations in CEP290. The deep intronic c.2991+1655A>G mutation in CEP290 is the most common mutation in LCA10 individuals and represents an ideal target for oligonucleotide therapeutics. Here, a panel…

  15. Journal Article

    Evaluation of Sleep Quality and Fatigue in Patients with Usher Syndrome Type 2a

    Jessie M. Hendricks, MSc; Juriaan R. Metz, PhD; Hedwig M. Velde, MSc et al.

    Ophthalmology Science, Vol. 3 No. 4 · 2023 · English · DOAJ Scopus

    Purpose: To study the prevalence, level, and nature of sleep problems and fatigue experienced by Usher syndrome type 2a (USH2a) patients. Design: Cross-sectional study. Participants: Fifty-six genetically confirmed Dutch patients with syndromic USH2a and 120 healthy controls. Methods: Sleep…

  16. Journal Article

    Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease

    Mubeen Khan; Gavin Arno; Ana Fakin et al.

    Molecular Therapy: Nucleic Acids, Vol. 21 · 2020 · English · DOAJ Scopus

    Stargardt disease is a progressive retinal disorder caused by bi-allelic mutations in the ABCA4 gene that encodes the ATP-binding cassette, subfamily A, member 4 transporter protein. Over the past few years, we and others have identified several pathogenic variants that reside within the introns of…